Click for best price
Dog Vaccines Market Size, Share 2022
Market Analysis and Insights: Global Dog Vaccines Market
The global Dog Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dog Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dog Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dog Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dog Vaccines market.
Global Dog Vaccines Scope and Market Size
Dog Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Dog Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segment by Application
Below 6 Months
Above Months
By Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Dog Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Dog Vaccines, with price, sales, revenue, and global market share of Dog Vaccines from 2019 to 2022.
Chapter 3, the Dog Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dog Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Dog Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dog Vaccines.
Chapter 13, 14, and 15, to describe Dog Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Dog Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Dog Vaccines Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
106 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Dog Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Dog Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Dog Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Below 6 Months
1.3.3 Above Months
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dog Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Dog Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Dog Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dog Vaccines Sales by Region
2.4.1 Global Dog Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Dog Vaccines by Region (2023-2028)
2.5 Global Dog Vaccines Revenue by Region
2.5.1 Global Dog Vaccines Revenue by Region (2017-2022)
2.5.2 Global Dog Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dog Vaccines Sales by Manufacturers
3.1.1 Global Top Dog Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Dog Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dog Vaccines in 2021
3.2 Global Dog Vaccines Revenue by Manufacturers
3.2.1 Global Dog Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Dog Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dog Vaccines Revenue in 2021
3.3 Global Dog Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dog Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dog Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dog Vaccines Sales by Type
4.1.1 Global Dog Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Dog Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Dog Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Dog Vaccines Revenue by Type
4.2.1 Global Dog Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Dog Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dog Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Dog Vaccines Price by Type
4.3.1 Global Dog Vaccines Price by Type (2017-2022)
4.3.2 Global Dog Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dog Vaccines Sales by Application
5.1.1 Global Dog Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Dog Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Dog Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Dog Vaccines Revenue by Application
5.2.1 Global Dog Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Dog Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dog Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Dog Vaccines Price by Application
5.3.1 Global Dog Vaccines Price by Application (2017-2022)
5.3.2 Global Dog Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dog Vaccines Market Size by Type
6.1.1 North America Dog Vaccines Sales by Type (2017-2028)
6.1.2 North America Dog Vaccines Revenue by Type (2017-2028)
6.2 North America Dog Vaccines Market Size by Application
6.2.1 North America Dog Vaccines Sales by Application (2017-2028)
6.2.2 North America Dog Vaccines Revenue by Application (2017-2028)
6.3 North America Dog Vaccines Market Size by Country
6.3.1 North America Dog Vaccines Sales by Country (2017-2028)
6.3.2 North America Dog Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dog Vaccines Market Size by Type
7.1.1 Europe Dog Vaccines Sales by Type (2017-2028)
7.1.2 Europe Dog Vaccines Revenue by Type (2017-2028)
7.2 Europe Dog Vaccines Market Size by Application
7.2.1 Europe Dog Vaccines Sales by Application (2017-2028)
7.2.2 Europe Dog Vaccines Revenue by Application (2017-2028)
7.3 Europe Dog Vaccines Market Size by Country
7.3.1 Europe Dog Vaccines Sales by Country (2017-2028)
7.3.2 Europe Dog Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dog Vaccines Market Size by Type
8.1.1 Asia Pacific Dog Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Dog Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Dog Vaccines Market Size by Application
8.2.1 Asia Pacific Dog Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Dog Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Dog Vaccines Market Size by Region
8.3.1 Asia Pacific Dog Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Dog Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dog Vaccines Market Size by Type
9.1.1 Latin America Dog Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Dog Vaccines Revenue by Type (2017-2028)
9.2 Latin America Dog Vaccines Market Size by Application
9.2.1 Latin America Dog Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Dog Vaccines Revenue by Application (2017-2028)
9.3 Latin America Dog Vaccines Market Size by Country
9.3.1 Latin America Dog Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Dog Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dog Vaccines Market Size by Type
10.1.1 Middle East and Africa Dog Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dog Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Dog Vaccines Market Size by Application
10.2.1 Middle East and Africa Dog Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dog Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Dog Vaccines Market Size by Country
10.3.1 Middle East and Africa Dog Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dog Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Corporation Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Healthcare Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Healthcare Recent Developments
11.2 Vetoquinol S.A
11.2.1 Vetoquinol S.A Corporation Information
11.2.2 Vetoquinol S.A Overview
11.2.3 Vetoquinol S.A Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vetoquinol S.A Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vetoquinol S.A Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Corporation Information
11.4.2 Ceva Overview
11.4.3 Ceva Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ceva Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Corporation Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 Heska Co.
11.6.1 Heska Co. Corporation Information
11.6.2 Heska Co. Overview
11.6.3 Heska Co. Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Heska Co. Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heska Co. Recent Developments
11.7 Merck Animal Health
11.7.1 Merck Animal Health Corporation Information
11.7.2 Merck Animal Health Overview
11.7.3 Merck Animal Health Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Animal Health Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Animal Health Recent Developments
11.8 Merial (Sanofi)
11.8.1 Merial (Sanofi) Corporation Information
11.8.2 Merial (Sanofi) Overview
11.8.3 Merial (Sanofi) Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merial (Sanofi) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial (Sanofi) Recent Developments
11.9 Virbac
11.9.1 Virbac Corporation Information
11.9.2 Virbac Overview
11.9.3 Virbac Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Virbac Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Virbac Recent Developments
11.10 Zoetis (Pfizer)
11.10.1 Zoetis (Pfizer) Corporation Information
11.10.2 Zoetis (Pfizer) Overview
11.10.3 Zoetis (Pfizer) Dog Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zoetis (Pfizer) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zoetis (Pfizer) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dog Vaccines Industry Chain Analysis
12.2 Dog Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dog Vaccines Production Mode & Process
12.4 Dog Vaccines Sales and Marketing
12.4.1 Dog Vaccines Sales Channels
12.4.2 Dog Vaccines Distributors
12.5 Dog Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dog Vaccines Industry Trends
13.2 Dog Vaccines Market Drivers
13.3 Dog Vaccines Market Challenges
13.4 Dog Vaccines Market Restraints
14 Key Findings in The Global Dog Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Dog Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Attenuated Live Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Inactivated Vaccines
Table 5. Major Manufacturers of Subunit Vaccines
Table 6. Major Manufacturers of Toxoid Vaccines
Table 7. Major Manufacturers of DNA Vaccines
Table 8. Major Manufacturers of Recombinant Vaccines
Table 9. Global Dog Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Dog Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Dog Vaccines Sales by Region (2017-2022) & (K Doses)
Table 12. Global Dog Vaccines Sales Market Share by Region (2017-2022)
Table 13. Global Dog Vaccines Sales by Region (2023-2028) & (K Doses)
Table 14. Global Dog Vaccines Sales Market Share by Region (2023-2028)
Table 15. Global Dog Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Dog Vaccines Revenue Market Share by Region (2017-2022)
Table 17. Global Dog Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Dog Vaccines Revenue Market Share by Region (2023-2028)
Table 19. Global Dog Vaccines Sales by Manufacturers (2017-2022) & (K Doses)
Table 20. Global Dog Vaccines Sales Share by Manufacturers (2017-2022)
Table 21. Global Dog Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Dog Vaccines Revenue Share by Manufacturers (2017-2022)
Table 23. Dog Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
Table 24. Global Dog Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Dog Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dog Vaccines as of 2021)
Table 26. Dog Vaccines Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Dog Vaccines Product Offered
Table 28. Date of Manufacturers Enter into Dog Vaccines Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 31. Global Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 32. Global Dog Vaccines Sales Share by Type (2017-2022)
Table 33. Global Dog Vaccines Sales Share by Type (2023-2028)
Table 34. Global Dog Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Dog Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Dog Vaccines Revenue Share by Type (2017-2022)
Table 37. Global Dog Vaccines Revenue Share by Type (2023-2028)
Table 38. Dog Vaccines Price by Type (2017-2022) & (USD/Dose)
Table 39. Global Dog Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
Table 40. Global Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 41. Global Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 42. Global Dog Vaccines Sales Share by Application (2017-2022)
Table 43. Global Dog Vaccines Sales Share by Application (2023-2028)
Table 44. Global Dog Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Dog Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Dog Vaccines Revenue Share by Application (2017-2022)
Table 47. Global Dog Vaccines Revenue Share by Application (2023-2028)
Table 48. Dog Vaccines Price by Application (2017-2022) & (USD/Dose)
Table 49. Global Dog Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)
Table 50. North America Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 51. North America Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 52. North America Dog Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Dog Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 55. North America Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 56. North America Dog Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Dog Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Dog Vaccines Sales by Country (2017-2022) & (K Doses)
Table 59. North America Dog Vaccines Sales by Country (2023-2028) & (K Doses)
Table 60. North America Dog Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Dog Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 63. Europe Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 64. Europe Dog Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Dog Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 67. Europe Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 68. Europe Dog Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Dog Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Dog Vaccines Sales by Country (2017-2022) & (K Doses)
Table 71. Europe Dog Vaccines Sales by Country (2023-2028) & (K Doses)
Table 72. Europe Dog Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Dog Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 75. Asia Pacific Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 76. Asia Pacific Dog Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Dog Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 79. Asia Pacific Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 80. Asia Pacific Dog Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Dog Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Dog Vaccines Sales by Region (2017-2022) & (K Doses)
Table 83. Asia Pacific Dog Vaccines Sales by Region (2023-2028) & (K Doses)
Table 84. Asia Pacific Dog Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Dog Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 87. Latin America Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 88. Latin America Dog Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Dog Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 91. Latin America Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 92. Latin America Dog Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Dog Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Dog Vaccines Sales by Country (2017-2022) & (K Doses)
Table 95. Latin America Dog Vaccines Sales by Country (2023-2028) & (K Doses)
Table 96. Latin America Dog Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Dog Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Dog Vaccines Sales by Type (2017-2022) & (K Doses)
Table 99. Middle East and Africa Dog Vaccines Sales by Type (2023-2028) & (K Doses)
Table 100. Middle East and Africa Dog Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Dog Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Dog Vaccines Sales by Application (2017-2022) & (K Doses)
Table 103. Middle East and Africa Dog Vaccines Sales by Application (2023-2028) & (K Doses)
Table 104. Middle East and Africa Dog Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Dog Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Dog Vaccines Sales by Country (2017-2022) & (K Doses)
Table 107. Middle East and Africa Dog Vaccines Sales by Country (2023-2028) & (K Doses)
Table 108. Middle East and Africa Dog Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Dog Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 110. Bayer Healthcare Corporation Information
Table 111. Bayer Healthcare Description and Major Businesses
Table 112. Bayer Healthcare Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Bayer Healthcare Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bayer Healthcare Recent Developments
Table 115. Vetoquinol S.A Corporation Information
Table 116. Vetoquinol S.A Description and Major Businesses
Table 117. Vetoquinol S.A Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Vetoquinol S.A Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Vetoquinol S.A Recent Developments
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Major Businesses
Table 122. Boehringer Ingelheim Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Boehringer Ingelheim Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Boehringer Ingelheim Recent Developments
Table 125. Ceva Corporation Information
Table 126. Ceva Description and Major Businesses
Table 127. Ceva Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. Ceva Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Ceva Recent Developments
Table 130. Eli Lilly Corporation Information
Table 131. Eli Lilly Description and Major Businesses
Table 132. Eli Lilly Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Eli Lilly Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Eli Lilly Recent Developments
Table 135. Heska Co. Corporation Information
Table 136. Heska Co. Description and Major Businesses
Table 137. Heska Co. Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. Heska Co. Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Heska Co. Recent Developments
Table 140. Merck Animal Health Corporation Information
Table 141. Merck Animal Health Description and Major Businesses
Table 142. Merck Animal Health Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Merck Animal Health Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Merck Animal Health Recent Developments
Table 145. Merial (Sanofi) Corporation Information
Table 146. Merial (Sanofi) Description and Major Businesses
Table 147. Merial (Sanofi) Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. Merial (Sanofi) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Merial (Sanofi) Recent Developments
Table 150. Virbac Corporation Information
Table 151. Virbac Description and Major Businesses
Table 152. Virbac Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 153. Virbac Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Virbac Recent Developments
Table 155. Zoetis (Pfizer) Corporation Information
Table 156. Zoetis (Pfizer) Description and Major Businesses
Table 157. Zoetis (Pfizer) Dog Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 158. Zoetis (Pfizer) Dog Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Zoetis (Pfizer) Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Dog Vaccines Distributors List
Table 163. Dog Vaccines Customers List
Table 164. Dog Vaccines Market Trends
Table 165. Dog Vaccines Market Drivers
Table 166. Dog Vaccines Market Challenges
Table 167. Dog Vaccines Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Dog Vaccines Product Picture
Figure 3. Global Dog Vaccines Market Share by Type in 2021 & 2028
Figure 3. Attenuated Live Vaccines Product Picture
Figure 4. Conjugate Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Toxoid Vaccines Product Picture
Figure 8. DNA Vaccines Product Picture
Figure 9. Recombinant Vaccines Product Picture
Figure 10. Global Dog Vaccines Market Share by Application in 2021 & 2028
Figure 11. Below 6 Months
Figure 12. Above Months
Figure 13. Dog Vaccines Report Years Considered
Figure 14. Global Dog Vaccines Sales 2017-2028 (K Doses)
Figure 15. Global Dog Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Dog Vaccines Revenue 2017-2028 (US$ Million)
Figure 17. Global Dog Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Dog Vaccines Sales Market Share by Region (2017-2022)
Figure 19. Global Dog Vaccines Sales Market Share by Region (2023-2028)
Figure 20. North America Dog Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 21. North America Dog Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Dog Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 23. Europe Dog Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Dog Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 25. Asia-Pacific Dog Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Dog Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 27. Latin America Dog Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Dog Vaccines Sales YoY (2017-2028) & (K Doses)
Figure 29. Middle East & Africa Dog Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Dog Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Dog Vaccines in the World: Market Share by Dog Vaccines Revenue in 2021
Figure 32. Global Dog Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 34. Global Dog Vaccines Revenue Market Share by Type (2017-2028)
Figure 35. Global Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 36. Global Dog Vaccines Revenue Market Share by Application (2017-2028)
Figure 37. North America Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 38. North America Dog Vaccines Revenue Market Share by Type (2017-2028)
Figure 39. North America Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 40. North America Dog Vaccines Revenue Market Share by Application (2017-2028)
Figure 41. North America Dog Vaccines Sales Share by Country (2017-2028)
Figure 42. North America Dog Vaccines Revenue Share by Country (2017-2028)
Figure 43. U.S. Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 46. Europe Dog Vaccines Revenue Market Share by Type (2017-2028)
Figure 47. Europe Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 48. Europe Dog Vaccines Revenue Market Share by Application (2017-2028)
Figure 49. Europe Dog Vaccines Sales Share by Country (2017-2028)
Figure 50. Europe Dog Vaccines Revenue Share by Country (2017-2028)
Figure 51. Germany Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 52. France Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Dog Vaccines Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Dog Vaccines Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Dog Vaccines Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Dog Vaccines Revenue Share by Region (2017-2028)
Figure 62. China Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. India Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 73. Latin America Dog Vaccines Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 75. Latin America Dog Vaccines Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Dog Vaccines Sales Share by Country (2017-2028)
Figure 77. Latin America Dog Vaccines Revenue Share by Country (2017-2028)
Figure 78. Mexico Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Dog Vaccines Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Dog Vaccines Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Dog Vaccines Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Dog Vaccines Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Dog Vaccines Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Dog Vaccines Revenue Share by Country (2017-2028)
Figure 87. Turkey Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 89. U.A.E Dog Vaccines Revenue (2017-2028) & (US$ Million)
Figure 90. Dog Vaccines Value Chain
Figure 91. Dog Vaccines Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
